| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/03/2011 | CN102140092A Hydrate of ilaprazole salt, preparation method thereof and application thereof |
| 08/03/2011 | CN102140091A Synthesis method of CCMP (Chloro Methyl Pyridine) |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN102140076A Preparation of mizolastine intermediate |
| 08/03/2011 | CN101633640B Naphthalimide derivative |
| 08/03/2011 | CN101597277B Novel method for preparing S-pantoprazole and salt |
| 08/03/2011 | CN101160287B 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative |
| 08/03/2011 | CN101133046B Preparation of ketone amides |
| 08/03/2011 | CN101119973B 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 08/02/2011 | US7990046 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989634 Melanocortin receptor agonists |
| 08/02/2011 | US7989632 Racemic 2[[(4-methoxy-3-methyl-2-pyridinyl)-methyl]sulfinyl]-5-(1H-pyrrol-1-yl)-1H-benzimidazole (ilaprazole) solvates having distinctive x-ray powder diffraction patterns and DSC thermograms; inhibiting gastric acid secretion; gastrointestinal inflammatory disorders; solubility, stability |
| 08/02/2011 | US7989631 Antiangiogenic drug AMG 706 hydrate phosphate salt; AMG 706 is known as motesanib, or N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide; oral administration; suspension; cancer |
| 08/02/2011 | US7989626 Modulators of cellular adhesion |
| 08/02/2011 | US7989624 Aryl spirolactam CGRP receptor antagonists |
| 08/02/2011 | US7989620 Hydantoin derivatives for the treatment of obstructive airway diseases |
| 08/02/2011 | US7989485 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
| 08/02/2011 | US7989477 Monocyclic heterocycles as kinase inhibitors |
| 08/02/2011 | US7989475 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/02/2011 | US7989462 4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | US7989460 Quinazoline derivatives as angiogenesis inhibitors |
| 08/02/2011 | US7989458 Pyrimidine derivatives as alk-5 inhibitors |
| 08/02/2011 | US7989457 Used to treat diabetic and other glucagon related metabolic disorders such as obesity, hyperglycemia, atherosclerosis, ischemic heart disease, stroke, neuropathy, and wound healing; (R,S)-Methanesulfonic acid 2-(3-methyl-4'-trifluoromethyl-biphenyl-4-yl)-propyl ester |
| 08/02/2011 | US7989455 Compounds, compositions and methods |
| 08/02/2011 | US7989453 Antitumor agents; for example, N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indole-3-yl]glyoxylamide |
| 08/02/2011 | US7989446 4-amino 5-cyanopyrimidine derivatives |
| 08/02/2011 | US7988997 Matrix of water soluble polymer; solidificated foam |
| 08/02/2011 | US7988950 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents |
| 08/02/2011 | CA2667966C Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 08/02/2011 | CA2642922C Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| 08/02/2011 | CA2538752C Quinazoline derivatives |
| 08/02/2011 | CA2537978C Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2489723C Novel aryl-{4-halo-4-[heteroaryl-methylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments |
| 08/02/2011 | CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 08/02/2011 | CA2475780C 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use to prepare drugs for treatment of immunological diseases |
| 08/02/2011 | CA2471577C Chemical compounds |
| 08/02/2011 | CA2463709C N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/28/2011 | WO2011090929A1 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
| 07/28/2011 | WO2011090911A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089576A2 NOVEL COMPOSITIONS FOR REDUCING Aß 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) |
| 07/28/2011 | WO2011089416A1 Pyrazine derivatives |
| 07/28/2011 | WO2011089132A1 Nitrogen-containing heteroaryl derivatives |
| 07/28/2011 | WO2011089099A1 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/28/2011 | WO2011088877A1 Compounds for electronic devices |
| 07/28/2011 | WO2011031327A3 Nicotine haptens, immunoconjugates and their uses |
| 07/28/2011 | US20110184183 Method for preparing a non-hydratable crystal form |
| 07/28/2011 | US20110184182 Compounds for producing substituted sulfoxides, process for producing the same and use thereof |
| 07/28/2011 | US20110184181 Electrochromic materials and electrochromic devices using the same |
| 07/28/2011 | US20110184173 Pyripyropene Derivatives Having An ACAT2-Inhibiting Activity |
| 07/28/2011 | US20110184023 The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide |
| 07/28/2011 | US20110184020 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions |
| 07/28/2011 | US20110183999 Novel polymorphic forms of methyl carbamate |
| 07/28/2011 | US20110183998 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 07/28/2011 | US20110183991 5ht7 receptor ligands and compositions comprising the same |
| 07/28/2011 | US20110183987 Stereoselective Synthesis of Bicyclic Heterocycles |
| 07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/28/2011 | US20110183981 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/28/2011 | US20110183980 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators |
| 07/28/2011 | US20110183979 Nitrogen-containing heteroaryl derivatives |
| 07/28/2011 | US20110183978 Phenylpyri(mi)dinylazoles |
| 07/28/2011 | US20110183977 Benzene, pyridine, and pyridazine derivatives |
| 07/28/2011 | US20110183976 5- and 6-membered heterocyclic compounds |
| 07/28/2011 | US20110183973 Novel Compounds |
| 07/28/2011 | US20110183966 Aminopyridine kinase inhibitors |
| 07/28/2011 | US20110183965 6-aminoisoquinoline compounds |
| 07/28/2011 | US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 07/28/2011 | US20110183958 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/28/2011 | US20110183957 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 07/28/2011 | US20110183954 Tricyclic 2,4-diamino-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders |
| 07/28/2011 | US20110183953 Selective heterocyclic sphingosine 1 phosphate receptor modulators |
| 07/28/2011 | US20110183952 New chemical compounds |
| 07/28/2011 | US20110183947 Alpha-keto heterocycles as faah inhibitors |
| 07/28/2011 | US20110183848 Piperazine Compounds With Herbicidal Effect |
| 07/28/2011 | US20110182850 Organic compounds and their uses |
| 07/28/2011 | US20110182812 Imaging Agents for Detecting Neurological Disorders |
| 07/28/2011 | DE102010005697A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices |
| 07/28/2011 | CA2788363A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2786666A1 Novel compositions for reducing abeta 42 production and their use in treating alzheimer's disease (ad) |
| 07/28/2011 | CA2786520A1 Pyrazine derivatives |
| 07/28/2011 | CA2786162A1 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 07/28/2011 | CA2783624A1 Heteroaryl compounds and uses thereof |
| 07/28/2011 | CA2782588A1 Nitrogen-containing heteroaryl derivatives |
| 07/27/2011 | EP2348019A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same |
| 07/27/2011 | EP2346856A1 2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors |
| 07/27/2011 | EP2346855A2 Process for making quinolone compounds |
| 07/27/2011 | EP2346854A2 Optical purification of esomeprazole |
| 07/27/2011 | EP2346853A2 Inhibitors of diacylglycerol acyltransferase |
| 07/27/2011 | EP2346852A1 Pyrrolidin-2-ones as hdm2 ligands |
| 07/27/2011 | EP2346851A2 Pyridine derivative or its salt, pesticide containing it and process for its production |
| 07/27/2011 | EP2346850A1 A method for the preparation of dabigatran and its intermediates |
| 07/27/2011 | EP2346849A1 Piperazine compounds with herbicidal effect |
| 07/27/2011 | EP2346848A1 Quinazoline derivatives as nk3 receptor antagonists |
| 07/27/2011 | EP2346834A1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives |
| 07/27/2011 | EP2346831A2 Heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 07/27/2011 | EP2346825A2 Modulators of p2x3 receptor activity |